800
Participants
Start Date
June 30, 2003
Primary Completion Date
February 29, 2008
Study Completion Date
March 31, 2008
Abciximab
Abciximab bolus and infusion is given. Study medication includes 3 identical vials, each with 5 ml solution containing 10 mg abciximab. The bolus dose to be given should be rated at 0.125 ml/kg of patient's weight. After the bolus, a total dose of 0.045 ml/kg study substance (up to a maximal quantity of 3.6 ml) should be given over 12 hours.
Placebo Heparin Sodium
Placebo bolus plus infusion is given. Study medication includes 3 identical vials, each with 5 ml solution containing 3000 U Heparin. The bolus dose to be given should be rated at 0.125 ml/kg of patient's weight. After the bolus, a total dose of 0.045 ml/kg study substance (up to a maximal quantity of 3.6 ml) should be given over 12 hours.
Allgemeines Krankenhaus Wien, Vienna
Deutsches Herzzentrum Muenchen, Munich
First Medizinische Klinik, Klinikum rechts der Isar, Munich
Klinikum Garmisch-Partenkirchen, Garmisch-Partenkirchen
Klinikum Traunstein, Traunstein
Technical University of Munich
OTHER
Deutsches Herzzentrum Muenchen
OTHER